ProSomnus Sleep Technologies has named Shouresh Charkhandeh, DDS, as its global scientific committee chair. Charkhandeh will collaborate with other clinicians to develop and publish research that systemically evaluates health outcomes for patients who are diagnosed with obstructive sleep apnea (OSA) and treated with oral appliance therapy (OAT).
Charkhandeh will assess and design relevant research to answer critical questions clinicians have in case selection among the many therapies offered for the treatment of OSA. Research minded clinicians will be invited to participate in this effort.
Len Liptak, CEO for ProSomnus, says in a release, “Dr Charkhandeh is uniquely qualified to guide and support research efforts that systemically evaluate the potential benefits of OAT on health outcomes for patients with OSA. We are honored to work with him.”
Charkhandeh has conducted evidence-based research for many years, including during his time with Zephyr Sleep Technologies, teaching within CharkEducation, and in completing a research fellowship in the area of “Sleep and Dental Sleep Medicine” at the University of Antwerp Hospital, in Antwerp, Belgium, where he is also currently working on his PhD. Charkhandeh has lectured at numerous sleep meetings across the world in the United States, Canada, Belgium, Netherlands, Germany, and Brazil. He won a 2012 & 2015 Clinical Research Award and a 2015 Clinical Excellence Award from the American Academy of Dental Sleep Medicine.
Dave Kuhns, PhD, chief science officer at ProSomnus Sleep Technologies, says in a release, “Dr Charkhandeh is an excellent and well qualified choice to lead this effort. We will facilitate and formalize this effort with the implementation of the ProSomnus Global Scientific Committee.”
Edward T. Sall, MD, DDS, MBA, Medical Director for ProSomnus, says in a release, “There are few clinicians and researchers that have contributed more evidence-based research to the field of dental sleep medicine than Dr Charkhandeh. His appointment as the global scientific committee Chair is a testament to the commitment of ProSomnus to increase the collaboration between physicians and dentists and coordinate clinical research leading to the growing acceptance of OAT in the treatment of OSA.”